229 related articles for article (PubMed ID: 9302277)
41. [Molecular basis of spinal muscular atrophy: th SMN gene].
Tizzano E; Baiget M
Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
43. Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems.
Charroux B; Pellizzoni L; Perkinson RA; Shevchenko A; Mann M; Dreyfuss G
J Cell Biol; 1999 Dec; 147(6):1181-94. PubMed ID: 10601333
[TBL] [Abstract][Full Text] [Related]
44. KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy.
Tadesse H; Deschênes-Furry J; Boisvenue S; Côté J
Hum Mol Genet; 2008 Feb; 17(4):506-24. PubMed ID: 17998247
[TBL] [Abstract][Full Text] [Related]
45. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy.
Trülzsch B; Davies K; Wood M
Brain Res Mol Brain Res; 2004 Jan; 120(2):145-50. PubMed ID: 14741404
[TBL] [Abstract][Full Text] [Related]
46. Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy.
Parker GC; Li X; Anguelov RA; Toth G; Cristescu A; Acsadi G
Neurotox Res; 2008 Jan; 13(1):39-48. PubMed ID: 18367439
[TBL] [Abstract][Full Text] [Related]
47. Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy.
Shin S; Park SS; Hwang YS; Lee KW; Chung SG; Lee YJ; Park MH
J Korean Med Sci; 2000 Feb; 15(1):93-8. PubMed ID: 10719817
[TBL] [Abstract][Full Text] [Related]
48. Refined characterization of the expression and stability of the SMN gene products.
Vitte J; Fassier C; Tiziano FD; Dalard C; Soave S; Roblot N; Brahe C; Saugier-Veber P; Bonnefont JP; Melki J
Am J Pathol; 2007 Oct; 171(4):1269-80. PubMed ID: 17717146
[TBL] [Abstract][Full Text] [Related]
49. Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein.
Gangwani L; Mikrut M; Theroux S; Sharma M; Davis RJ
Nat Cell Biol; 2001 Apr; 3(4):376-83. PubMed ID: 11283611
[TBL] [Abstract][Full Text] [Related]
50. A survival motor neuron:tetanus toxin fragment C fusion protein for the targeted delivery of SMN protein to neurons.
Francis JW; Figueiredo D; vanderSpek JC; Ayala LM; Kim YS; Remington MP; Young PJ; Lorson CL; Ikebe S; Fishman PS; Brown RH
Brain Res; 2004 Jan; 995(1):84-96. PubMed ID: 14644474
[TBL] [Abstract][Full Text] [Related]
51. Treatment of spinal muscular atrophy by sodium butyrate.
Chang JG; Hsieh-Li HM; Jong YJ; Wang NM; Tsai CH; Li H
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9808-13. PubMed ID: 11504946
[TBL] [Abstract][Full Text] [Related]
52. Histologic and transcriptional assessment of a mild SMA model.
Balabanian S; Gendron NH; MacKenzie AE
Neurol Res; 2007 Jul; 29(5):413-24. PubMed ID: 17535551
[TBL] [Abstract][Full Text] [Related]
53. Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.
Helmken C; Hofmann Y; Schoenen F; Oprea G; Raschke H; Rudnik-Schöneborn S; Zerres K; Wirth B
Hum Genet; 2003 Dec; 114(1):11-21. PubMed ID: 14520560
[TBL] [Abstract][Full Text] [Related]
54. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.
Jablonka S; Schrank B; Kralewski M; Rossoll W; Sendtner M
Hum Mol Genet; 2000 Feb; 9(3):341-6. PubMed ID: 10655542
[TBL] [Abstract][Full Text] [Related]
55. Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport.
Béchade C; Rostaing P; Cisterni C; Kalisch R; La Bella V; Pettmann B; Triller A
Eur J Neurosci; 1999 Jan; 11(1):293-304. PubMed ID: 9987032
[TBL] [Abstract][Full Text] [Related]
56. Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene.
Gambardella A; Mazzei R; Toscano A; Annesi G; Pasqua A; Annesi F; Quattrone F; Oliveri RL; Valentino P; Bono F; Aguglia U; Zappia M; Vita G; Quattrone A
Ann Neurol; 1998 Nov; 44(5):836-9. PubMed ID: 9818944
[TBL] [Abstract][Full Text] [Related]
57. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
[TBL] [Abstract][Full Text] [Related]
58. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
Mattis VB; Rai R; Wang J; Chang CW; Coady T; Lorson CL
Hum Genet; 2006 Nov; 120(4):589-601. PubMed ID: 16951947
[TBL] [Abstract][Full Text] [Related]
59. Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy.
Schwartz M; Sørensen N; Hansen FJ; Hertz JM; Nørby S; Tranebjaerg L; Skovby F
Hum Mol Genet; 1997 Jan; 6(1):99-104. PubMed ID: 9002676
[TBL] [Abstract][Full Text] [Related]
60. Post-translational modifications in the survival motor neuron protein.
La Bella V; Kallenbach S; Pettmann B
Biochem Biophys Res Commun; 2004 Nov; 324(1):288-93. PubMed ID: 15465016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
